Affiliation:
1. Research and Diagnostic Center, Centers for Disease Control, Taipei, Taiwan
2. Division of Infectious Diseases, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
Abstract
ABSTRACT
Acinetobacter
spp. have emerged as important nosocomial and multidrug-resistant pathogens in the last decade.
A. calcoaceticus
,
A. baumannii
,
Acinetobacter
genospecies 3, and
Acinetobacter
genospecies 13TU are genetically closely related and are referred to as the
A. calcoaceticus-A. baumannii
complex (ACB complex). Distinct
Acinetobacter
spp. may be associated with differences in antimicrobial susceptibility, so it is important to identify
Acinetobacter
spp. at the species level. We developed a microsphere-based array that combines an allele-specific primer extension assay and microsphere hybridization for the identification of
Acinetobacter
spp. This assay can discriminate the 13 different
Acinetobacter
spp. in less than 8.5 h, and it has high specificity without causing cross-reactivity with 14 other common nosocomial bacterial species. The sensitivity of this assay was 100
A. baumannii
cells per ml of blood, and it could discriminate multiple species in various mixture ratios. The developed assay could differentiate clinical
Acinetobacter
spp. isolates with a 90% identification rate. The antimicrobial susceptibility test showed that
A. baumannii
isolates were resistant to most antimicrobial agents other than imipenem, while the genospecies 3 and 13TU isolates were more susceptible to most antimicrobial agents, especially ciprofloxacin and ampicillin-sulbactam. These results supported the idea that this assay possibly could be applied to clinical samples and provide accurate species identification, which might be helpful for clinicians when they are treating infections caused by
Acinetobacter
spp.
Publisher
American Society for Microbiology
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献